Review decisions

Showing 250 results of 292 total
Summary Safety Review - VOTRIENT (pazopanib) - Assessing the Potential Risk of Accumulation of Fluid Around the Heart (Pericardial Effusion)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00009
Issued / Original Publication Date: 2015-11-30
Summary Safety Review - AVASTIN (bevacizumab) - Assessing the Potential Risk of Irreversible Vocal Cord Damage (vocal cord necrosis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00010
Issued / Original Publication Date: 2015-11-30
Summary Safety Review - ABILIFY and ABILIFY MAINTENA (aripiprazole) - Evaluating the Risk of Certain Impulse Control Behaviours
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00011
Issued / Original Publication Date: 2015-11-02
Summary Safety Review - Strontium - Risk of Heart and Circulatory Side Effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00012
Issued / Original Publication Date: 2015-10-22
Summary Safety Review - Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors INVOKANA (canagliflozin) and FORXIGA (dapagliflozin) - Evaluation of a Potential Risk of Acute Kidney Injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00062
Issued / Original Publication Date: 2015-10-16
Summary Safety Review - OCTAGAM 5% and OCTAGAM 10% (Immune Globulin Intravenous [Human]) - Assessing Lack of Effectiveness and Safety Issues Related To the Manufacturing Process
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00014
Issued / Original Publication Date: 2015-09-29
Summary Safety Review - REMICADE (infliximab) - Evaluating for the Risk of Cancer (Lymphoma, Hepatosplenic T-Cell Lymphoma, and Leukemia)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00015
Issued / Original Publication Date: 2015-09-29
Summary Safety Review - GILENYA (fingolimod) - Assessing the Risk of the Abnormal Tissue Growth (Cancer)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00016
Issued / Original Publication Date: 2015-09-14
Summary Safety Review - REVOLADE (eltrombopag) - Serious Skin Reactions
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00017
Issued / Original Publication Date: 2015-09-10
Summary Safety Review - Bortezomib (VELCADE and Generics) - Assessing a Potential Link with Flesh-Eating Disease (Necrotising Fasciitis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00018
Issued / Original Publication Date: 2015-09-03

Displaying 241 - 250 of 292 | Page 25 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: